Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 1,320 shares at $3.22 ($4K) on 2019-07-11, disclosed to the SEC on 2019-07-15.
Open-market purchase of $4k ORMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ORMP.OB | BUY | 2011-10-06 | $300K | — | Filing → |
| ORMP | BUY | 2008-01-17 | $5K | — | Filing → |
| ORMP | BUY | 2008-01-09 | $7K | — | Filing → |